1-8 of 8
secondary prevention
Close
Sort by
Journal Articles

Brandão LR, Albisetti M, Halton J, et al; DIVERSITY Study Investigators. Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children. Blood. 2020;135(7):491-504.

Journal: Blood
Blood (2020) 135 (19): 1720.
https://doi.org/10.1182/blood.2020005941
Published: 2020
Journal Articles

Outcomes in the Secondary Prevention of Cerebral Venous Thrombosis in Cancer Only Population

Nadia Isabel Abelhad, MDBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 5063.
https://doi.org/10.1182/blood-2018-99-110298
Published: 2018
Journal Articles

Data of Real-Life Anticoagulant Treatment in Patients Diagnosed with Nonvalvular Atrial Fibrillation and Secondary Prevention of Venous Thromboembolic Disease with Edoxaban: Experience in Our Center

Maria Almudena Garcia Ruiz, Marta Rivas Luque, Pablo Romero Garcia, MDCINE Resident, Manuel Jurado, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4920.
https://doi.org/10.1182/blood.V130.Suppl_1.4920.4920
Published: 2017
Journal Articles

Low- Molecular Weight Heparins (LMWH) Versus Vitamin K Antagonists (VKAs) in the Treatment and Secondary Prevention of Cancer-Associated Venous Thromboembolism (VTE): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)

Kyaw Zin Thein, MD MBBS, Lukman Tijani, MD, Thein H. Oo, MD FACP, FRCP
Journal: Blood
Blood (2016) 128 (22): 1180.
https://doi.org/10.1182/blood.V128.22.1180.1180
Published: 2016
Journal Articles

Rationale and Design of a Phase III Safety Trial of Idarucizumab in Children Receiving Dabigatran Etexilate for the Treatment and Secondary Prevention of Venous Thromboembolism

Manuela Albisetti, MD, Arno Schlosser, MSc, Martina Brueckmann, MD, Savion Gropper, MD, Stephan Glund, PhD, Igor Tartakovsky, MD, Leonardo R. Brandão, MD MSc, Paul A Reilly, PhD
Journal: Blood
Blood (2016) 128 (22): 5010.
https://doi.org/10.1182/blood.V128.22.5010.5010
Published: 2016
Journal Articles

Rationale and Design of a Phase III Single-Arm Multicenter Study of Dabigatran Etexilate for the Secondary Prevention of Venous Thromboembolism in Children

Matteo Luciani, Manuela Albisetti, MD, Ivan Manastirski, Martina Brueckmann, MD, Savion Gropper, MD, Igor Tartakovsky, MD, Bushi Wang, Branislav Biss, Lesley G Mitchell, Fenglei Huang, Jacqueline ML Halton, MD, Leonardo R. Brandão, MD MSc
Journal: Blood
Blood (2016) 128 (22): 5028.
https://doi.org/10.1182/blood.V128.22.5028.5028
Published: 2016
Journal Articles

Vitamin supplementation in the secondary prevention of venous thromboembolism: about the VITRO study

Rossella Marcucci, Francesco Sofi, Anna Maria Gori, Gian Franco Gensini, Rosanna Abbate
Journal: Blood
Blood (2007) 109 (12): 5520.
https://doi.org/10.1182/blood-2007-01-071415
Published: 2007
Journal Articles

Homocysteine Lowering by B Vitamins and the Secondary Prevention of Deep-Vein Thrombosis and Pulmonary Embolism. A First Randomised, Placebo-Controlled, Double-Blind Trial.

Gerard M.J. Bos, MD, PhD, Martin Heijer den, MD, PhD, Huub Willems, MD, Henk Blom, PhD, Wim Gerrits, MD, Marco Cattaneo, MD, Sabine Eichinger, MD, Frits Rosendaal, MD
Journal: Blood
Blood (2004) 104 (11): 489.
https://doi.org/10.1182/blood.V104.11.489.489
Published: 2004